InvestLog
CRVS logo

CRVS

Corvus Pharmaceuticals, Inc.NASDAQHealthcare
$14.69+1.80%ClosedMarket Cap: $1.23B

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-13Oppenheimer—Outperform—
2026-01-22Jefferies—Buy—
2026-01-21Barclays—Overweight—
2026-01-21Oppenheimer—Outperform—
2026-01-20HC Wainwright & Co.—Buy—
2025-05-20Mizuho—Outperform—
2025-05-09Oppenheimer—Outperform—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-0.78$20.8M4
Sun Dec 31$-0.64$58.2M6
Mon Dec 31$-0.46$130.1M4
Tue Dec 31$0.12$235.8M2